IV 
110TH CONGRESS 
1ST SESSION 
H. CON. RES. 182 
Recognizing the need to pursue research into the causes, a treatment, and 
an eventual cure for idiopathic pulmonary fibrosis, supporting the goals 
and ideals of National Idiopathic Pulmonary Fibrosis Awareness Week, 
and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
JULY 12, 2007 
Mr. DEAL of Georgia (for himself, Mr. BAIRD, Mr. CASTLE, Mr. UPTON, Mr. 
WESTMORELAND, Mr. GINGREY, and Mr. MILLER of North Carolina) 
submitted the following concurrent resolution; which was referred to the 
Committee on Energy and Commerce 
CONCURRENT RESOLUTION 
Recognizing the need to pursue research into the causes, 
a treatment, and an eventual cure for idiopathic pul-
monary fibrosis, supporting the goals and ideals of Na-
tional Idiopathic Pulmonary Fibrosis Awareness Week, 
and for other purposes. 
Whereas idiopathic pulmonary fibrosis is a serious lung dis-
order causing progressive, incurable lung scarring; 
Whereas idiopathic pulmonary fibrosis is one of about 200 
disorders called interstitial lung diseases; 
Whereas idiopathic pulmonary fibrosis is the most common 
form of interstitial lung disease; 
VerDate Aug 31 2005 
05:43 Jul 13, 2007
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HC182.IH
HC182
ccoleman on PROD1PC69 with BILLS
•HCON 182 IH 
Whereas idiopathic pulmonary fibrosis is a debilitating and 
generally fatal disease marked by progressive scarring of 
the lungs, causing an irreversible loss of the lung tissue’s 
ability to transport oxygen; 
Whereas idiopathic pulmonary fibrosis progresses quickly, 
often causing disability or death within a few short years; 
Whereas there is no proven cause of idiopathic pulmonary fi-
brosis; 
Whereas more than 128,000 United States citizens have idio-
pathic pulmonary fibrosis, and more than 48,000 new 
cases are diagnosed each year representing a 156-percent 
increase in mortality since 2001; 
Whereas idiopathic pulmonary fibrosis is often misdiagnosed 
or under diagnosed; 
Whereas the median survival rate for idiopathic pulmonary fi-
brosis patients is 2 to 3 years; about two-thirds of idio-
pathic pulmonary fibrosis patients die within 5 years; and 
approximately 40,000 patients die each year; and 
Whereas a need has been identified to increase awareness and 
detection of this misdiagnosed and under diagnosed dis-
order as well as all incarnations of pulmonary fibrosis: 
Now, therefore, be it 
Resolved by the House of Representatives (the Senate 
concurring), That the Congress— 
(1) recognizes the need to pursue research into 
the causes, a treatment, and an eventual cure for id-
iopathic pulmonary fibrosis; 
(2) supports the work of advocates and organi-
zations in educating, supporting, and providing hope 
VerDate Aug 31 2005 
05:43 Jul 13, 2007
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\HC182.IH
HC182
ccoleman on PROD1PC69 with BILLS
•HCON 182 IH 
for individuals who suffer from idiopathic pulmonary 
fibrosis, including efforts to organize a National Idi-
opathic Pulmonary Fibrosis Awareness Week; 
(3) supports the designation of an appropriate 
week as National Idiopathic Pulmonary Fibrosis 
Awareness Week; 
(4) welcomes the issuance of a proclamation 
designating a National Idiopathic Pulmonary Fibro-
sis Awareness Week; 
(5) congratulates advocates and organizations 
for their efforts to educate the public about idio-
pathic pulmonary fibrosis, while funding research to 
help find a cure for this disorder; and 
(6) supports the goals and ideals of National 
Idiopathic Pulmonary Fibrosis Awareness Week. 
Æ 
VerDate Aug 31 2005 
05:43 Jul 13, 2007
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\HC182.IH
HC182
ccoleman on PROD1PC69 with BILLS